Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: weakness, increased abdominal girth, major surgical or invasive procedure: 1. tracheostomy placement 2. peg tube placement history of present illness: pt is a 64 yo m with h/o dm2, cad s/p recent hospitalization for rhabdomyolyis and myopathy presenting with weakness. pt states that since d/c on he has experienced progressively worsening weakness. he states that he has the most difficulty getting out of chair, changing clothes, not as much weakness at the wrists or ankle. no diplopia or blurry vision, no dysphagia, no headache or jaw pain. pt denies any myalgias, no paraesthesis. on the previous hospitalization his cholesterol lowering agents were discontinued as it was thought that these could be the possible culprits for rhabdomyolysis. during that hospitalization neurology was consulted, and work up included nl tsh, elevated esr, negative . pt's health has been deteriorating over the past year in the setting of a chronic post surgical would infection at the left foot requiring most recently vancomycin. he was started on zyvox 4 days prior to this presentation. of note, during his prior hospitalization he complained of sob and had an oxygen requirement. echo demonstrated an ef of % and it was felt that he possibly had diastolic heart failure. he responded to gentle diuresis with subjective improvement in symptoms. pulmonary was consulted at that time and recommended outpt sleep study. his hospital course results were also remarkable for persistently elevated lfts. an mri was planned to further evaluate but pt was unable to fit in mri due to abdominal girth. . in the ed his labs were notable for elevated ck to < . this was higher than the ck max at the prior hospitalization. he was given 1l ns. . ros: positive for mild sob which he says is unchanged since discharge - overall improved over the past month since starting diuretics; denies cp/palp/cough/diarrhea/rash. past medical history: iddm, htn, afib w/ anticoagulation therapy gout, hypercholesterolemia, arthritis cad psh: s/p l 5th ray amputation s/p r inguinal hernia repair s/p cholecystectomy s/p coronary artery by pass surgery x4 s/p l tma social history: retired postal worker, married, 4 children, no tobacco, no drugs use, etoh qweek, wife involved family history: mother died of liver cancer in her 70's physical exam: vs: 130/80, hr 87, rr 16, 89% ra, 96% 2l oxygen gen - nad heent - perrl, extraocular motions intact, anicteric, mucous membranes moist neck - jvp 8cm, no cervical lymphadenopathy chest - cta bl cv - irrg/irreg nl s1 s2 no mrg abd - obese, nt, nd, nabs back - no costovertebral angle tendernes, no sacral edema extr - no clubbing, cyanosis, 1+ edema to mid shin bl left - foot surgical scar wound neuro - alert and oriented x 3, cranial nerves intact, ue strength 5/5 except for deltoid (), le except for hip extensors (); sensation intact skin - no rash pertinent results: 05:30pm glucose-120* urea n-43* creat-1.4* sodium-138 potassium-4.2 chloride-100 total co2-28 anion gap-14 05:42pm lactate-1.5 05:30pm alt(sgpt)-542* ast(sgot)-573* ck(cpk)-* alk phos-63 tot bili-0.5 05:30pm lipase-39 05:30pm wbc-8.5 rbc-4.15* hgb-12.3* hct-35.8* mcv-86 mch-29.6 mchc-34.4 rdw-16.4* 05:30pm neuts-79.3* lymphs-14.2* monos-4.6 eos-1.6 basos-0.4 05:30pm anisocyt-1+ microcyt-1+ 05:30pm plt count-192 . cxr--bibasilar atelectasis, cardiomegaly . . final diagnosis: right deltoid muscle biopsy (including snap-frozen tissue): acute, recent, and chronic myopathy (chronic active myopathy) acute myofiber necrosis. scattered degenerating and regenerating myofibers and scattered myophagocytosis, indicative of recent myofiber injury. increased endomysial connective tissue, increased frequency of internalized nuclei, and scattered split myofibers, indicative of chronic myopathy. scattered cd4 and cd8 t-lymphocytes, without direct association with pathologic changes. coarse lipid and mitochondrial staining in degenerating myofibers. note: in addition to the findings identified in the preliminary report, these special stains identify coarse lipid staining in many of the degenerating myofibers, along with corresponding changes in mitochondria. while not specific, they are consistent with a metabolic myopathy affecting lipid metabolism, as can be induced by toxic agents and several drugs. they are consistent with effects of some cholesterol lower agents, especially combinations of agents in elderly patients. diagnostic changes of an inflammatory myositis are not identified in this biopsy. microscopic description: h&e stain: increased internalized nuclei and split myofibers; scattered myophagocytosis and frequent degenerating and regenerating myofibers, including atrophic basophilic fibers; moderate to marked variation in myofiber size; frequent small, round or angulated myofibers; scattered acutely necrotic myofibers having pale eosinophilic staining gomori trichrome stain: increased endomysial connective tissue in sites of greatest degeneration; no ragged red fibers; degenerating myofibers often show coarse staining of sarcoplasmic mitochondria pas stain: normal distribution of glycogen pas + diastase stain: no diastase-resistant glycogen oil red "o" stain: coarse staining of degenerating myofibers nadh histochemistry: coarse staining of degenerating myofibers in a mitochondrial pattern (mitochondrial clumping) atpase (ph 4.3, 4.6, 9.5) histochemistry: type i myofiber predominant; atrophic myofibers of both types - predominantly type ii; no diagnostic type grouping. cd3 immunoperoxidase: non-contributory cd4 immunoperoxidase: scattered t4 lymphocytes throughout specimen; not directly associated with individual myofiber injury cd8 immunoperoxidase: scattered t8 lymphocytes throughout specimen; not directly associated with individual myofiber injury cd68 immunoperoxidase: non-contributory factor viii immunoperoxidase: normal numbers of vessels, including endomysial capillaries brief hospital course: a/p: 64yo man with h/o tiidm, cad, afib, and gout, presenting with myositis vs rhabdomyalysis, transferred now with tachypnea and hypercapnia and acidemia. . # respiratory failure poor ventilation due to progressive muscle weakness. rising pco2 and respiratory acidemia progressed to hypercarbic respiratory failure. no evidence of primary pulmonary process. - pt intubated for worsening ventilation/oxygenation in setting of worsening weakness - remained intubated due to poor nifs. very brief sbt failed when pt had no respiratory effort. -given continued poor respiratory muscle strength, likelihood of lengthy intubation, percutaneous tracheostomy performed on and trach placed. complicated trach placement due to subcutaneous emphysema on same day of trach placement. incision site was widened and subcutaneous emphysema and swelling decreased over the next two days. no pneumothorax or pneumomediastinum seen on cxr. . # myospathy: rhabdomyolysis/myopathy, pathololgy from muscle biopsy suggests myopathic changes, possibly drug-induced. rheumatology and neurology consulted. not thought that steroids will help this disease process. off statins, will follow ck and clinical picture, await gradual recovery. . # arf: contrast nephropathy, atn on chronic diabetic nephrophathy. patient briefly anuric. hemodialyzed, but now with improving renal function, increased urine output, no further need for dialysis at this time. . # transaminitis: lfts returned to nl; likely due to rhabdo. hepatitis serologies negative. cta abdomen nondiagnostic . # foot wound: patient completed 10days linezolid per podiatry recc's. podiatry following. . # tiidm: riss + nph for elevated blood sugars. . # htn: metoprolol . # fen: diabetic, cardiac diet; peg placed on . # ppx: sc heparin, po diet . # access: picc . # full code medications on admission: allopurinol 200 mg po daily aspirin 81 mg po daily clonidine 0.3 mg/24 hr patch weekly qsat irbesartan 300 mg po qd warfarin 5 mg po 6x/week (mo,tu,we,th,fr,sa) docusate sodium 100 mg po bid omega-3 fatty acids 550 mg po bid gabapentin 300 mg po bid folic acid 1 mg po daily cyanocobalamin 1,000 mcg/ml for 7 days. furosemide 40 mg po daily metoprolol tartrate 50 mg po bid insulin nph-regular discharge medications: 1. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewable po daily (daily). 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) as needed. 3. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). 4. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po daily (daily) as needed. 5. gabapentin 100 mg capsule sig: two (2) capsule po daily (daily). 6. allopurinol 100 mg tablet sig: one (1) tablet po every other day (every other day). 7. heparin (porcine) 5,000 unit/ml solution sig: one (1) injection tid (3 times a day). 8. miconazole nitrate 2 % powder sig: one (1) appl topical qid (4 times a day) as needed. 9. lansoprazole 30 mg susp,delayed release for recon sig: one (1) po daily (daily). 10. acetylcysteine 20 % (200 mg/ml) solution sig: one (1) ml miscell. q4-6h (every 4 to 6 hours) as needed. 11. olanzapine 5 mg tablet sig: one (1) tablet po daily (daily). 12. albuterol 90 mcg/actuation aerosol sig: 1-2 puffs inhalation q6h (every 6 hours) as needed. 13. ipratropium bromide 17 mcg/actuation aerosol sig: two (2) puff inhalation q4-6h (every 4 to 6 hours) as needed. 14. citalopram 20 mg tablet sig: one (1) tablet po daily (daily). 15. warfarin 5 mg tablet sig: one (1) tablet po hs (at bedtime). 16. metoprolol tartrate 50 mg tablet sig: two (2) tablet po tid (3 times a day). 17. hydralazine 20 mg/ml solution sig: one (1) injection q6h (every 6 hours) as needed for sbp>155. 18. vancomycin hcl 1000 mg iv q 12h discharge disposition: extended care facility: & rehab center - discharge diagnosis: 1. myopathy 2. respiratory failure discharge condition: good discharge instructions: - please take all medications as prescribed. - return if you have any worsening weakness, any worsening muscle cramping, chest pain, dizziness, faintness, or any other concerning symptoms. followup instructions: please follow up with your primary care physician 1 week of discharge. procedure: venous catheterization, not elsewhere classified continuous invasive mechanical ventilation for 96 consecutive hours or more insertion of endotracheal tube fiber-optic bronchoscopy fiber-optic bronchoscopy enteral infusion of concentrated nutritional substances hemodialysis venous catheterization for renal dialysis non-invasive mechanical ventilation percutaneous [endoscopic] gastrostomy [peg] temporary tracheostomy open biopsy of soft tissue transfusion of other serum diagnoses: obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery pure hypercholesterolemia acute kidney failure with lesion of tubular necrosis urinary tract infection, site not specified congestive heart failure, unspecified unspecified essential hypertension acute kidney failure, unspecified gout, unspecified atrial fibrillation aortocoronary bypass status peripheral vascular disease, unspecified chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease acute and chronic respiratory failure long-term (current) use of anticoagulants acute diastolic heart failure diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled rhabdomyolysis infection (chronic) of amputation stump nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use 

Answer: The patient is high likely exposed to